All In Biotech

Drug Trial Radar · NCT00065962

Secretin for the Treatment of Autism

Multisite Controlled Secretin Trial in Autism

Last checked: Nov 19, 2026Latest source record: Jun 24, 2005 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

85

Actual

Start

Jun 1999

Primary completion

Not stated

Study completion May 2000

Sponsor

Sponsor type
NIH
Collaborators
National Institute on Deafness and Other Communication Disorders (NIDCD)
First posted
Aug 5, 2003

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Factorial
Masking
Double
Primary purpose
Treatment
Who can join
All sexes, from 3 years, up to 12 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Many drugs used to treat autism target specific symptoms, such as hyperactivity and aggressiveness. Few drugs target the core autistic symptoms of impaired social interaction and communication. This study will evaluate two forms of the drug secretin for the treatment of core autistic symptoms.

Conditions

  • Autism

Interventions

  • secretin, synthetic porcineDrug

  • secretin, biologically derived porcineDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

No primary outcomes listed.

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Children's Hospital

    Denver, Colorado

  • Center on Human Development and Disability

    Seattle, Washington

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.